Feasibility of Intensive Chemotherapy in Hereditary Spherocytosis
This experience underscores the importance of a multidisciplinary approach and tailored treatment plans for patients with co-existing conditions, suggesting that HS should not automatically disqualify them from potentially curative therapies for aggressive lymphomas.
Authors
- Alessandro Maria Vannucchi (ORCID: https://orcid.org/0000-0001-5755-0730)
- CS Juan Manuel
- N. Luca
- Carrai Valentina
- Giubbilei Cristina
- D’Angelo Simona
- Sordi Benedetta
- Puccini Benedetta
Institutions
- Azienda Ospedaliero-Universitaria Careggi (IT)
- University of Florence (IT)
Publication Details
- Journal
- Hematology Reports
- Published
- 2025-02-24
- DOI
- https://doi.org/10.3390/hematolrep17020011
- Primary Topic
- Erythrocyte Function and Pathophysiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00